T&L Future Growth
Future criteria checks 4/6
T&L is forecast to grow earnings and revenue by 20.7% and 18.7% per annum respectively. EPS is expected to grow by 20.6% per annum. Return on equity is forecast to be 23.1% in 3 years.
Key information
20.7%
Earnings growth rate
20.6%
EPS growth rate
| Medical Equipment earnings growth | 40.9% |
| Revenue growth rate | 18.7% |
| Future return on equity | 23.1% |
| Analyst coverage | Low |
| Last updated | 26 Apr 2024 |
Recent future growth updates
Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 12/31/2026 | 204,900 | 51,300 | N/A | 52,700 | 1 |
| 12/31/2025 | 171,200 | 45,600 | 31,000 | 44,950 | 2 |
| 12/31/2024 | 139,900 | 36,200 | 23,000 | 39,000 | 2 |
| 12/31/2023 | 115,461 | 27,439 | 17,689 | 32,591 | N/A |
| 9/30/2023 | 116,228 | 29,825 | 7,438 | 25,346 | N/A |
| 6/30/2023 | 106,663 | 27,672 | -2,837 | 19,803 | N/A |
| 3/31/2023 | 93,828 | 24,779 | -3,773 | 14,960 | N/A |
| 12/31/2022 | 81,577 | 21,118 | -598 | 15,407 | N/A |
| 9/30/2022 | 81,192 | 21,723 | 5,849 | 17,684 | N/A |
| 6/30/2022 | 79,005 | 22,387 | 13,017 | 21,495 | N/A |
| 3/31/2022 | 72,099 | 20,274 | 6,161 | 21,021 | N/A |
| 12/31/2021 | 71,896 | 19,585 | 2,990 | 19,006 | N/A |
| 9/30/2021 | 63,257 | 17,158 | 2,356 | 18,592 | N/A |
| 6/30/2021 | 53,601 | 14,675 | 1,151 | 13,834 | N/A |
| 3/31/2021 | 46,383 | 11,651 | 5,833 | 12,286 | N/A |
| 12/31/2020 | 40,633 | 10,042 | 5,905 | 9,344 | N/A |
| 9/30/2020 | 36,014 | 9,540 | 5,876 | 8,431 | N/A |
| 3/31/2020 | 34,212 | 7,499 | 3,847 | 7,134 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: A340570's forecast earnings growth (20.7% per year) is above the savings rate (2.5%).
Earnings vs Market: A340570's earnings (20.7% per year) are forecast to grow slower than the KR market (28.4% per year).
High Growth Earnings: A340570's earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: A340570's revenue (18.7% per year) is forecast to grow faster than the KR market (9.1% per year).
High Growth Revenue: A340570's revenue (18.7% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: A340570's Return on Equity is forecast to be high in 3 years time (23.1%)